The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Tackling heart failure in the twenty-first century
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,902
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Writing Group Members, Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S. M., Ho, M., Howard, V., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.187998 · Cited by 3,711
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111303 · Cited by 3,125
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
Packer, M., Carver, J. R., Rodeheffer, R. J., Ivanhoe, R. J., DiBianco, R., Zeldis, S. M., Hendrix, G. H., Bommer, W. J., Elkayam, U., Kukin, M. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252103 · Cited by 2,225
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells
Ebert, M. S., Neilson, J. R., & Sharp, P. A. (2007) · Nature Methods · doi:10.1038/nmeth1079 · Cited by 2,108
Oss, J. M., Areba, W. O. Z., Ackson, W. J., Lein, H. E. K., Ilber, D. A. J. W., Annom, D. A. S. C., Ames, J. M., Aubert, P., Iggins, S. T. L. H., Rown, M. A. W. B., et al. (2002) · Cited by 2,027
PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor)
Marx, S. O., Reiken, S., Hisamatsu, Y., Jayaraman, T., Burkhoff, D., Rosemblit, N., & Marks, A. R. (2000) · Cell · doi:10.1016/s0092-8674(00)80847-8 · Cited by 1,978
Regulation of cardiac hypertrophy by intracellular signalling pathways
Heineke, J., & Molkentin, J. D. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1983 · Cited by 1,866
MicroRNA-133 controls cardiac hypertrophy
Carè, A., Catalucci, D., Felicetti, F., Bonci, D., Addario, A., Gallo, P., Bang, M.-L., Segnalini, P., Gu, Y., Dalton, N. D., et al. (2007) · Nature Medicine · doi:10.1038/nm1582 · Cited by 1,776
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
Taylor, A. L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, R., Ferdinand, K., Taylor, M., Adams, K., Sabolinski, M., Worcel, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042934 · Cited by 1,773
Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., et al. (2005) · Nature Medicine · doi:10.1038/nm0405-367 · Cited by 1,677
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., & Fowler, M. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00477-9 · Cited by 1,661
Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007) · Science · doi:10.1126/science.1139089 · Cited by 1,657
The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress
Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., Omiya, S., Mizote, I., Matsumura, Y., Asahi, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1574 · Cited by 1,520
Peroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M., & Kelly, D. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10268 · Cited by 1,285
Mann, D. L., McMurray, J. J. V., Packer, M., Swedberg, K., Borer, J. S., Colucci, W. S., Djian, J., Drexler, H., Feldman, A., Kober, L., et al. (2004) · Circulation · doi:10.1161/01.cir.0000124490.27666.b2 · Cited by 1,240
Vega, R. B., Huss, J. M., & Kelly, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1868-1876.2000 · Cited by 1,195
Yang, B., Lin, H., Xiao, J., Lu, Y., Luo, X., Li, B., Zhang, Y., Xu, C., Bai, Y., Wang, H., et al. (2007) · Nature Medicine · doi:10.1038/nm1569 · Cited by 1,138
A Mutation in the TRPC6 Cation Channel Causes Familial Focal Segmental Glomerulosclerosis
Winn, M. P., Conlon, P. J., Lynn, K. L., Farrington, M. K., Creazzo, T., Hawkins, A. F., Daskalakis, N., Kwan, S. Y., Ebersviller, S., Burchette, J. L., et al. (2005) · Science · doi:10.1126/science.1106215 · Cited by 1,104
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
McKinsey, T. A., Zhang, C.-L., Lu, J., & Olson, E. N. (2000) · Nature · doi:10.1038/35040593 · Cited by 1,052
Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy
Zhang, C. L., McKinsey, T. A., Chang, S., Antos, C. L., Hill, J. A., & Olson, E. N. (2002) · Cell · doi:10.1016/s0092-8674(02)00861-9 · Cited by 973
Shiojima, I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24682 · Cited by 939
p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload
Sano, M., Minamino, T., Toko, H., Miyauchi, H., Orimo, M., Qin, Y., Akazawa, H., Tateno, K., Kayama, Y., Harada, M., et al. (2007) · Nature · doi:10.1038/nature05602 · Cited by 905
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
Takimoto, E., Champion, H. C., Li, M., Belardi, D., Ren, S., Rodriguez, E. R., Bedja, D., Gabrielson, K. L., Wang, Y., & Kass, D. A. (2005) · Nature Medicine · doi:10.1038/nm1175 · Cited by 903
Self-citationLeft Ventricular Assist Device and Drug Therapy for the Reversal of Heart Failure
Birks, E. J., Tansley, P. D., Hardy, J., George, R. S., Bowles, C. T., Burke, M., Banner, N. R., Khaghani, A., & Yacoub, M. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053063 · Cited by 885
Knöll, R., Hoshijima, M., Hoffman, H. M., Person, V., Lorenzen-Schmidt, I., Bang, M.-L., Hayashi, T., Shiga, N., Yasukawa, H., Schaper, W., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01226-6 · Cited by 786
Role of Oxidative Stress in Cardiac Hypertrophy and Remodeling
Takimoto, E., & Kass, D. A. (2007) · Hypertension · doi:10.1161/01.hyp.0000254415.31362.a7 · Cited by 770
Self-citationA mechanistic role for cardiac myocyte apoptosis in heart failure
Wencker, D., Chandra, M., Nguyen, K., Miao, W., Garantziotis, S., Factor, S. M., Shirani, J., Armstrong, R. C., & Kitsis, R. N. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17664 · Cited by 765 · cited 1×
“Apoptosis can be initiated by multiple pathways — including those triggered by ROS, angiotensin II, sympathetic stimulation or cytokines — and a low, but significantly abnormal, rate of cardiomyocyte apoptosis seems to contribute to the phenotype of heart failur”
BackgroundCardiac autophagy is a maladaptive response to hemodynamic stress
Zhu, H., Tannous, P., Johnstone, J. L., Kong, Y., Shelton, J. M., Richardson, J. A., Le, V., Levine, B., Rothermel, B. A., & Hill, J. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci27523 · Cited by 764
Stressing the role of FoxO proteins in lifespan and disease
van der Horst, A., & Burgering, B. M. T. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2190 · Cited by 759
The Giant Protein Titin: A Major Player in Myocardial Mechanics, Signaling, and Disease
Granzier, H. L., & Labeit, S. (2004) · Circulation Research · doi:10.1161/01.res.0000117769.88862.f8 · Cited by 649
Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats
Li, M., Zheng, C., Sato, T., Kawada, T., Sugimachi, M., & Sunagawa, K. (2004) · Circulation · doi:10.1161/01.cir.0000105721.71640.da · Cited by 612
PKC-α regulates cardiac contractility and propensity toward heart failure
Braz, J. C., Gregory, K., Pathak, A., Zhao, W., Sahin, B., Klevitsky, R., Kimball, T. F., Lorenz, J. N., Nairn, A. C., Liggett, S. B., et al. (2004) · Nature Medicine · doi:10.1038/nm1000 · Cited by 595
Calmodulin kinase II inhibition protects against structural heart disease
Zhang, R., Khoo, M. S. C., Wu, Y., Yang, Y., Grueter, C. E., Ni, G., Price, E. E., Thiel, W., Guatimosim, S., Song, L.-S., et al. (2005) · Nature Medicine · doi:10.1038/nm1215 · Cited by 579
TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling
Kuwahara, K., Wang, Y., McAnally, J., Richardson, J. A., Bassel-Duby, R., Hill, J. A., & Olson, E. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27702 · Cited by 561
Miyamoto, M. I., del Monte, F., Schmidt, U., DiSalvo, T. S., Kang, Z. B., Matsui, T., Guerrero, J. L., Gwathmey, J. K., Rosenzweig, A., & Hajjar, R. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.793 · Cited by 530
Small, K. M., Wagoner, L. E., Levin, A. M., Kardia, S. L. R., & Liggett, S. B. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020803 · Cited by 530
McKinsey, T. A., Zhang, C. L., & Olson, E. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.260501497 · Cited by 517
Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy
Dávila-Román, V. G., Vedala, G., Herrero, P., de las Fuentes, L., Rogers, J. G., Kelly, D. P., & Gropler, R. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01967-8 · Cited by 513
Lowes, B. D., Minobe, W., Abraham, W. T., Rizeq, M. N., Bohlmeyer, T. J., Quaife, R. A., Roden, R. L., Dutcher, D. L., Robertson, A. D., Voelkel, N. F., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119770 · Cited by 503
Myocardial Gene Expression in Dilated Cardiomyopathy Treated with Beta-Blocking Agents
Lowes, B. D., Gilbert, E. M., Abraham, W. T., Minobe, W. A., Larrabee, P., Ferguson, D., Wolfel, E. E., Lindenfeld, J., Tsvetkova, T., Robertson, A. D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012630 · Cited by 501
Nagueh, S. F., Shah, G., Wu, Y., Torre-Amione, G., King, N. M. P., Lahmers, S., Witt, C. C., Becker, K., Labeit, S., & Granzier, H. L. (2004) · Circulation · doi:10.1161/01.cir.0000135591.37759.af · Cited by 486
Protection from Cardiac Arrhythmia Through Ryanodine Receptor-Stabilizing Protein Calstabin2
Wehrens, X. H. T., Lehnart, S. E., Reiken, S. R., Deng, S.-X., Vest, J. A., Cervantes, D., Coromilas, J., Landry, D. W., & Marks, A. R. (2004) · Science · doi:10.1126/science.1094301 · Cited by 480
Wu, X. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27374 · Cited by 478
Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo
Antos, C. L., McKinsey, T. A., Frey, N., Kutschke, W., McAnally, J., Shelton, J. M., Richardson, J. A., Hill, J. A., & Olson, E. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231619298 · Cited by 477
Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3β activity
Trivedi, C. M., Luo, Y., Yin, Z., Zhang, M., Zhu, W., Wang, T., Floss, T., Goettlicher, M., Noppinger, P. R., Wurst, W., et al. (2007) · Nature Medicine · doi:10.1038/nm1552 · Cited by 468
Liggett, S. B., Mialet-Perez, J., Thaneemit-Chen, S., Weber, S. A., Greene, S. M., Hodne, D., Nelson, B., Morrison, J., Domanski, M. J., Wagoner, L. E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509937103 · Cited by 454
Takimoto, E., Champion, H. C., Li, M., Ren, S., Rodriguez, E. R., Tavazzi, B., Lazzarino, G., Paolocci, N., Gabrielson, K. L., Wang, Y., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200521968 · Cited by 450
Self-citationGlycogen Synthase Kinase-3β: A Novel Regulator of Cardiac Hypertrophy and Development
Hardt, S. E., & Sadoshima, J. (2002) · Circulation Research · doi:10.1161/01.res.0000018952.70505.f1 · Cited by 438
Oka, T., Maillet, M., Watt, A. J., Schwartz, R. J., Aronow, B. J., Duncan, S. A., & Molkentin, J. D. (2006) · Circulation Research · doi:10.1161/01.res.0000215985.18538.c4 · Cited by 423
β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
Noma, T., Lemaire, A., Naga Prasad, S. V., Barki-Harrington, L., Tilley, D. G., Chen, J., Le Corvoisier, P., Violin, J. D., Wei, H., Lefkowitz, R. J., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31901 · Cited by 418
TRPC3 and TRPC6 are essential for angiotensin II‐induced cardiac hypertrophy
Onohara, N., Nishida, M., Inoue, R., Kobayashi, H., Sumimoto, H., Sato, Y., Mori, Y., Nagao, T., & Kurose, H. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601417 · Cited by 411
Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure
Nakayama, H., Chen, X., Baines, C. P., Klevitsky, R., Zhang, X., Zhang, H., Jaleel, N., Chua, B. H. L., Hewett, T. E., Robbins, J., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31060 · Cited by 405
Function of cGMP-Dependent Protein Kinases as Revealed by Gene Deletion
Hofmann, F., Feil, R., Kleppisch, T., & Schlossmann, J. (2006) · Physiological Reviews · doi:10.1152/physrev.00015.2005 · Cited by 395
Balijepalli, R. C., Foell, J. D., Hall, D. D., Hell, J. W., & Kamp, T. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503465103 · Cited by 393
Arany, Z., Novikov, M., Chin, S., Ma, Y., Rosenzweig, A., & Spiegelman, B. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603615103 · Cited by 374
Wettschureck, N., Rütten, H., Zywietz, A., Gehring, D., Wilkie, T. M., Chen, J., Chien, K. R., & Offermanns, S. (2001) · Nature Medicine · doi:10.1038/nm1101-1236 · Cited by 373
Altered Cardiac Myocyte Ca Regulation In Heart Failure
Bers, D. M. (2006) · Physiology · doi:10.1152/physiol.00019.2006 · Cited by 363
Type 5 Adenylyl Cyclase Disruption Increases Longevity and Protects Against Stress
Yan, L., Vatner, D. E., O'Connor, J. P., Ivessa, A., Ge, H., Chen, W., Hirotani, S., Ishikawa, Y., Sadoshima, J., & Vatner, S. F. (2007) · Cell · doi:10.1016/j.cell.2007.05.038 · Cited by 353
ATP flux through creatine kinase in the normal, stressed, and failing human heart
Weiss, R. G., Gerstenblith, G., & Bottomley, P. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408962102 · Cited by 350
Liggett, S. B., Wagoner, L. E., Craft, L. L., Hornung, R. W., Hoit, B. D., McIntosh, T. C., & Walsh, R. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4059 · Cited by 341
The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
Liao, P., Georgakopoulos, D., Kovacs, A., Zheng, M., Lerner, D., Pu, H., Saffitz, J., Chien, K., Xiao, R.-P., Kass, D. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211086598 · Cited by 333
Self-citationPerez, J. M., Rathz, D. A., Petrashevskaya, N. N., Hahn, H. S., Wagoner, L. E., Schwartz, A., Dorn, G. W., & Liggett, S. B. (2003) · Nature Medicine · doi:10.1038/nm930 · Cited by 333
Death begets failure in the heart
Foo, R., Mani, K. M., & Kitsis, R. N. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524569 · Cited by 309
Curran, J., Hinton, M. J., Ríos, E., Bers, D. M., & Shannon, T. R. (2007) · Circulation Research · doi:10.1161/01.res.0000258172.74570.e6 · Cited by 303
Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy
Hayashi, T., Arimura, T., Itoh-Satoh, M., Ueda, K., Hohda, S., Inagaki, N., Takahashi, M., Hori, H., Yasunami, M., Nishi, H., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.08.058 · Cited by 302
Heerdt, P. M., Holmes, J. W., Cai, B., Barbone, A., Madigan, J. D., Reiken, S., Lee, D. L., Oz, M. C., Marks, A. R., & Burkhoff, D. (2000) · Circulation · doi:10.1161/01.cir.102.22.2713 · Cited by 296
Perrino, C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25397 · Cited by 268
Genetic causes of human heart failure
Morita, H., Seidman, J. G., & Seidman, C. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524351 · Cited by 264
Xiao, R.-P. (2001) · Science's STKE · doi:10.1126/stke.2001.104.re15 · Cited by 264
Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart
Heineke, J., Auger-Messier, M., Xu, J., Oka, T., Sargent, M. A., York, A., Klevitsky, R., Vaikunth, S., Duncan, S. A., Aronow, B. J., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32573 · Cited by 234
Pathak, A., del Monte, F., Zhao, W., Schultz, J.-E., Lorenz, J. N., Bodi, I., Weiser, D., Hahn, H., Carr, A. N., Syed, F., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000161256.85833.fa · Cited by 228
Frey, N., Barrientos, T., Shelton, J. M., Frank, D., Rütten, H., Gehring, D., Kuhn, C., Lutz, M., Rothermel, B., Bassel-Duby, R., et al. (2004) · Nature Medicine · doi:10.1038/nm1132 · Cited by 223
Phosphodiesterase Type 5: Expanding Roles in Cardiovascular Regulation
Kass, D. A., Champion, H. C., & Beavo, J. A. (2007) · Circulation Research · doi:10.1161/circresaha.107.162511 · Cited by 217
Self-citationNuclear Targeting of Akt Enhances Kinase Activity and Survival of Cardiomyocytes
Shiraishi, I., Melendez, J., Ahn, Y., Skavdahl, M., Murphy, E., Welch, S., Schaefer, E., Walsh, K., Rosenzweig, A., Torella, D., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000124394.01180.be · Cited by 212
White, D. C., Hata, J. A., Shah, A. S., Glower, D. D., Lefkowitz, R. J., & Koch, W. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090091197 · Cited by 208
Upregulation of TRPC1 in the development of cardiac hypertrophy
Ohba, T., Watanabe, H., Murakami, M., Takahashi, Y., Iino, K., Kuromitsu, S., Mori, Y., Ono, K., Iijima, T., & Ito, H. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.10.020 · Cited by 205
Mechanisms and Use of Calcium-Sensitizing Agents in the Failing Heart
Kass, D. A., & Solaro, R. J. (2006) · Circulation · doi:10.1161/circulationaha.105.542407 · Cited by 188
Self-citationWagoner, L. E., Craft, L. L., Singh, B., Suresh, D. P., Zengel, P. W., McGuire, N., Abraham, W. T., Chenier, T. C., Dorn, G. W., & Liggett, S. B. (2000) · Circulation Research · doi:10.1161/01.res.86.8.834 · Cited by 173
Lai, N. C., Roth, D. M., Gao, M. H., Tang, T., Dalton, N., Lai, Y. Y., Spellman, M., Clopton, P., & Hammond, H. K. (2004) · Circulation · doi:10.1161/01.cir.0000136033.21777.4d · Cited by 168
Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface
McKinsey, T. A., & Kass, D. A. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2193 · Cited by 163
Self-citationImai, M., Rastogi, S., Gupta, R. C., Mishra, S., Sharov, V. G., Stanley, W. C., Mika, Y., Rousso, B., Burkhoff, D., Ben‐Haim, S. A., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.082 · Cited by 156
The Tumor Suppressor Gene PTEN Can Regulate Cardiac Hypertrophy and Survival
Schwartzbauer, G., & Robbins, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102479200 · Cited by 142
Reversal of Global Apoptosis and Regional Stress Kinase Activation by Cardiac Resynchronization
Chakir, K., Daya, S. K., Tunin, R. S., Helm, R. H., BYRNE, M. J., Dimaano, V. L. J., Lardo, A. C., Abraham, T. P., Tomaselli, G. F., & Kass, D. A. (2008) · Circulation · doi:10.1161/circulationaha.107.706291 · Cited by 130
Self-citationInhibition of Glycogen Synthase Kinase 3β During Heart Failure Is Protective
Hirotani, S., Zhai, P., Tomita, H., Galeotti, J., Marquez, J. P., Gao, S., Hong, C., Yatani, A., Ávila, J., & Sadoshima, J. (2007) · Circulation Research · doi:10.1161/circresaha.107.160614 · Cited by 123
Many good reasons to have STAT3 in the heart
Hilfiker-Kleiner, D., Hilfiker, A., & Drexler, H. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.02.003 · Cited by 115
Pathobiology of Left Ventricular Dyssynchrony and Resynchronization
SPRAGG, D. D., & Kass, D. A. (2006) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2006.05.001 · Cited by 114
Self-citationForfia, P. R., Lee, M., Tunin, R. S., Mahmud, M., Champion, H. C., & Kass, D. A. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.066 · Cited by 111
Self-citationSex- and age-dependent human transcriptome variability: Implications for chronic heart failure
Boheler, K. R., Volkova, M. V., Morrell, C., Garg, R., Zhu, Y. Z., Margulies, K. B., Seymour, A. L., & Lakatta, E. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0436564100 · Cited by 106
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure
Taylor, A. L., Ziesche, S., & Yancy, C. W. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.02.045 · Cited by 101
Alterations in energy metabolism in cardiomyopathies
Taha, M., & Lopaschuk, G. D. (2007) · Annals of Medicine · doi:10.1080/07853890701618305 · Cited by 99
Modification of myocardial substrate use as a therapy for heart failure
Abozguia, K., Clarke, K. J., Lee, L., & Frenneaux, M. P. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0583 · Cited by 91
Brodde, O. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-006-0125-7 · Cited by 78
Zhai, P., Gao, S., Holle, E., Yu, X., Yatani, A., Wagner, T. E., & Sadoshima, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705133200 · Cited by 76
Small, K. M., Wagoner, L. E., Levin, S. M., et al. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00063-1 · Cited by 73
Cardiac Hypertrophy and Reduced Contractility in Hearts Deficient in the Titin Kinase Region
Peng, J., Raddatz, K., Molkentin, J. D., Wu, Y., Labeit, S., Granzier, H. L. M., & Gotthardt, M. (2007) · Circulation · doi:10.1161/circulationaha.106.645499 · Cited by 72
Cited by
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
Semenza, G. L. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104720 · Cited by 1,159
Cell Death in the Pathogenesis of Heart Disease: Mechanisms and Significance
Whelan, R. S., Kaplinskiy, V., & Kitsis, R. N. (2010) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163111 · Cited by 759
Braunwald, E. (2013) · JACC: Heart Failure · doi:10.1016/j.jchf.2012.10.002 · Cited by 730
Adrenergic Nervous System in Heart Failure: Pathophysiology and Therapy
Lymperopoulos, A., Rengo, G., & Koch, W. J. (2013) · Circulation Research · doi:10.1161/circresaha.113.300308 · Cited by 607
Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics
Li, Z.-M., Xu, S.-W., & Liu, P.-Q. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.193 · Cited by 564
Metadata
- Authors
- Mudd, J. O., & Kass, D. A.
- Venue
- Nature
- Published
- 2008-02
- Volume
- 451
- Issue
- 7181
- Pages
- 919-928
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2068337616
- Cited by
- 406
- References
- 102
- FWCI
- 22.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.